Spots Global Cancer Trial Database for Dose-range Finding Treosulfan-based Conditioning
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Dose-range Finding Treosulfan-based Conditioning
Official Title: Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Advanced Hematological Malignancies After Treosulfan-based Conditioning Therapy - A Clinical Phase II Study
Study ID: NCT01063647
Conditions
Study Description
Brief Summary: Evaluation of the safety and efficacy of 3 x 10, 3 x 12 or 3 x 14 g/m² Treosulfan resp., combined with 5 x 30 mg/m² fludarabine prior to allogeneic, hematopoietic stem cell transplantation of patients with hematological malignancies, but non-eligible to standard conditioning treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Helsinki University Central Hospital, Helsinki, , Finland
Charité University Hospital Berlin, Berlin, , Germany
University Hospital Hamburg Eppendorf, Hamburg, , Germany
5th Medical Clinic, Clinic North, Nuremberg, , Germany
University Hospital Rostock, Rostock, , Germany
Silesian Medical University, Katowice, , Poland
Karolinska University Hospital & Karolinska Institute, Stockholm, , Sweden
Contact Details
Name: Mathias Freund, MD
Affiliation: University Hospital Rostock
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
